Journal of the American Academy of Dermatology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Analysis of general payments from industry to dermatology nonphysician clinicians in the United States, 2021-2022
To the Editor: The 2013 inauguration of Open Payments elevated the transparency of financial transactions connecting the healthcare industry and physicians and in 2021 extended its scope to encompass nonphysician clinicians (NPCs).1 Despite existing characterization of the workforce attributes of NPCs in dermatology,2 payments to NPCs are unexplored and important to investigate, given the potential for conflicts of interest that may impact practice. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 1, 2024 Category: Dermatology Authors: Nicole J. Hardy, Christian Gronbeck, Hao Feng Tags: Research letter Source Type: research

Photobiomodulation CME Part I: Overview and Mechanism of Action
Photobiomodulation (PBM), previously known as low-level laser light therapy, represents a non-invasive form of phototherapy that utilizes wavelengths in the red light (RL, 620-700 nm) portion of the visible light (VL, 400-700 nm) spectrum and the near-infrared (NIR, 700-1440 nm) spectrum. PBM is a promising and increasingly used therapy for the treatment of various dermatologic and non-dermatologic conditions. Photons from RL and NIR are absorbed by endogenous photoreceptors including mitochondrial cytochrome C oxidase (COX). (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - February 1, 2024 Category: Dermatology Authors: Jalal Maghfour, David M. Ozog, Jessica Mineroff, Jared Jagdeo, Indermeet Kohli, Henry W. Lim Tags: Continuing Medical Education Source Type: research

Ethical Implications of No-Show Fees in Dermatology: Balancing Practice Needs and Patient Concerns
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 31, 2024 Category: Dermatology Authors: Alana L. Ferreira, Jeromy W. Gotschall, Jane M. Grant-Kels Source Type: research

Safety Profile of Guselkumab in Treatment of Patients with Psoriasis and Coexisting Hepatitis B or C: A Multicenter Prospective Cohort Study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 31, 2024 Category: Dermatology Authors: Yu-Huei Huang, Ju-Shao Yen, Shu-Hao Li, Hsien-Yi Chiu Source Type: research

Higher Risk of Melanoma-related Deaths for Patients Residing in Rural Counties: A Surveillance, Epidemiology, and End Results Program Study
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 31, 2024 Category: Dermatology Authors: Sarah Kooper-Johnson, Viknesh Kasthuri, Alexander Homer, Bichchau Michelle Nguyen Source Type: research

Photobiomodulation CME Part II: Clinical Applications in Dermatology
Photobiomodulation (PBM) is an emerging treatment modality in dermatology with increasing office and home-based use. PBM is the use of various light sources in the red light (620-700 nm) and near-infrared (700-1440 nm) spectrum as a form of light therapy. PBM is often administered through low-level lasers or light-emitting diodes. Studies show that PBM can be used effectively to treat conditions secondary to cancer therapies, alopecia, ulcers, herpes simplex virus, acne, skin rejuvenation, wounds, and scars. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 31, 2024 Category: Dermatology Authors: Jessica Mineroff, Jalal Maghfour, David D. Ozog, Henry W. Lim, Indermeet Kohli, Jared Jagdeo Tags: Continuing Medical Education Source Type: research

Elevated risk of subsequent primary malignancies in patients with dermatofibrosarcoma protuberans: an updated retrospective cohort analysis of the Surveillance, Epidemiology, and End Results Program
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 31, 2024 Category: Dermatology Authors: Tejas P. Joshi, Ikue Shimizu Source Type: research

Emulsifiers are not necessary to make formulas for deep chemical peeling: Response to Wambier et  al., “Advanced chemical peels: Phenol-croton oil peel”
Septisol (SEP), one of the 4 ingredients of Dr T. Baker's formula (1961) and also Dr Greg Hetter's1 formulas, has been banned by the Food and Drug Administration and is no longer available for deep chemical peels. SEP is an emulsifying (soap) agent for water, pure phenol and croton oil, and has been a key ingredient for decades. Do we need an emulsifier? We believe the answer is no, as the history of deep peels documents and through our own extensive experience (Table I). (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Peter Rullan, Marina Landau, Jennifer Rullan Tags: JAAD Online Source Type: research

Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study
Solid organ transplant recipients (SOTRs) are believed to have an increased risk of metastatic cutaneous squamous cell carcinoma (cSCC), but reliable data are lacking regarding the precise incidence and associated risk factors. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Estella de Jong, Roel Genders, Catherine A. Harwood, Ad èle C. Green, Elsemieke I. Plasmeijer, Charlotte Proby, Edward Geissler, Carla Ferrándiz-Pulido, Emilie Ducroux, Sylvie Euvrard, Alexandra Geusau, Karin Jahn-Bassler, Liliane Borik-Heil, Emõke Rá Tags: Original article Source Type: research

Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patients
Cutaneous lupus erythematosus (CLE) may present as an isolated entity or be classified as Systemic lupus erythematosus (SLE) by the presence of laboratory abnormalities, including cytopenia, low complement levels, and/or autoantibodies (CLE with laboratory SLE). (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Cl émence Masseran, Laura Perray, Quitterie Murat de Montai, Alexis Mathian, Alexandre Teboul, Camille Francès, Laurent Arnaud, Nathalie Costedoat-Chalumeau, Zahir Amoura, Delphine S. Courvoisier, Annick Barbaud, François Chasset Tags: Original article Source Type: research

Guidelines of care for the management of acne vulgaris
Acne vulgaris commonly affects adults, adolescents, and preadolescents aged 9  years or older. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Rachel V. Reynolds, Howa Yeung, Carol E. Cheng, Fran Cook-Bolden, Seemal R. Desai, Kelly Druby, Esther E. Freeman, Jonette E. Keri, Linda F. Stein Gold, Jerry K.L. Tan, Megha M. Tollefson, Jonathan S. Weiss, Peggy A. Wu, Andrea L. Zaenglein, Jung Min Han, Tags: From the academy Source Type: research

Cumulative incidence and risk factors for cutaneous squamous-cell carcinoma metastases in organ transplant recipients: the SCOPE-ITSCC metastases study, a prospective multi-center study.
Solid organ transplant recipients (SOTRs) are believed to have an increased risk of metastatic cutaneous squamous-cell carcinoma (cSCC), but reliable data are lacking regarding the precise incidence and associated risk factors. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Estella de Jong, Roel Genders, Catherine A. Harwood, Ad èle C. Green, Elsemieke I. Plasmeijer, Charlotte Proby, Edward Geissler, Carla Ferrándiz-Pulido, Emilie Ducroux, Sylvie Euvrard, Alexandra Geusau, Karin Jahn-Bassler, Liliane Borik-Heil, Emõke Rá Source Type: research

Comparison of patients with isolated cutaneous erythematosus (CLE) versus SLE with CLE as the sole clinical feature: a monocentric study of 149 patients
Cutaneous lupus erythematosus (CLE) may present as an isolated entity or be classified as Systemic lupus erythematosus (SLE) by the presence of laboratory abnormalities including cytopenia, low complement levels and/or autoantibodies (CLE with laboratory SLE). (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Cl émence Masseran, Laura Perray, Quitterie Murat de Montai, Alexis Mathian, Alexandre Teboul, Camille Francès, Laurent Arnaud, Nathalie Costedoat-Chalumeau, Annick Barbaud, Zahir Amoura, Delphine S. Courvoisier, François Chasset Source Type: research

Emulsifiers are not necessary to make formulas for Deep Chemical Peeling: response to Wambier et al. ’s “Advanced chemical peels: Phenol-croton oil peel.”
(Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 30, 2024 Category: Dermatology Authors: Peter Rullan, Marina Landau, Jennifer Rullan Source Type: research

Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase  3, randomized, double-blind, placebo-controlled trial
Despite high disease burden, systemic treatment options for patients with atopic hand and/or foot dermatitis (H/F AD) are limited. (Source: Journal of the American Academy of Dermatology)
Source: Journal of the American Academy of Dermatology - January 29, 2024 Category: Dermatology Authors: Eric L. Simpson, Jonathan I. Silverberg, Margitta Worm, Golara Honari, Koji Masuda, Ewa Sygu ła, Marie L.A. Schuttelaar, Eric Mortensen, Elizabeth Laws, Bolanle Akinlade, Naimish Patel, Jennifer Maloney, Heather Paleczny, Dimittri Delevry, Jing Xiao, Ari Tags: Original article Source Type: research